Formulation and methods for the treatment of thrombocythemia

Details Formulation and methods for the treatment of thrombocythemia Formulation and methods for the treatment of thrombocythemia

A - Human Necessities

61

K

A61K 31/517 (2006.01) A61K 9/70 (2006.01)

Patent

CA 2513708

The present invention provides a method for the treatment or prevention of thrombocythemia in a patient comprising administering to said patient an effective amount of anagrelide, anagrelide in base form, or a pharmaceutically acceptable salt of anagrelide in a manner whereby first pass liver metabolism is avoided.

La présente invention porte sur une méthode de traitement ou de prévention de la thrombocythémie chez un patient consistant à administrer audit patient une quantité efficace d'anagrélide, sous sa forme de base, ou un sel pharmaceutiquement acceptable d'anagrélide de manière à éviter un métabolisme de premier passage hépatique.

Affiliated with

Also associated with

Rating

Formulation and methods for the treatment of thrombocythemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation and methods for the treatment of thrombocythemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation and methods for the treatment of thrombocythemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1886338